Sprouting of adult Purkinje cell axons in lesioned mouse cerebellum: "non-permissive" versus "permissive" environment.
Adult rat Purkinje cells are extremely resistant to axotomy and, although they lack spontaneous regeneration, are able to sprout. Axon sprouting is a late process that occurs mainly 6 to 18 months after the lesion and results from an interplay between Purkinje cell intrinsic properties and chemical remodeling of the glial scar. To better appraise the role of the local environment in the late sprouting, we performed new axotomy experiments in mice. In this species, unlike the rat, there is no cavitation because the post-lesional necrotic tissue is invaded by astrocytes and incorporated into the glial scar. In this scarring tissue, chondroitin sulfate proteoglycans (CS-PGs) and PSA-NCAM are present one week after the lesion, but the time courses of their expression differ: the former are transiently expressed and rapidly disappears (by one month), thus preventing early sprouting and providing a negative spatiotemporal correlation with the late sprouting. PSA-NCAM expression, which is maintained up till 12 months, is by itself not sufficient to attract the sprouts, since the core of the glial scar--which exhibits high level of PSA-NCAM--is always devoid of them. Finally, by using a double experimental approach (lesion and graft) aimed at providing a permissive environment to the terminal bulbs of axotomized Purkinje cells, we show that the presence of grafted cerebellum at the lesion site neither changes the time course of the sprouting nor enhances the Purkinje cell axonal regeneration. Nevertheless, these experiments have revealed a new type of altered Purkinje cells, the "irritated" Purkinje cells with a high potentiality for axon sprouting.
D000818:Animals; D001253:Astrocytes / Q000166:cytology / Q000502:physiology; D019771:Axotomy; D016380:Brain Tissue Transplantation; D002450:Cell Communication / Q000502:physiology; D002531:Cerebellum / Q000166:cytology* / Q000254:growth & development* / Q000378:metabolism; D011508:Chondroitin Sulfate Proteoglycans / Q000378:metabolism; D005260:Female; D005911:Gliosis / Q000503:physiopathology; D006085:Graft Survival / Q000502:physiology; D020439:Growth Cones / Q000378:metabolism / Q000648:ultrastructure*; D051379:Mice; D017628:Microglia / Q000166:cytology / Q000502:physiology; D009416:Nerve Regeneration / Q000502:physiology*; D039842:Neural Cell Adhesion Molecule L1 / Q000378:metabolism; D009473:Neuronal Plasticity / Q000502:physiology*; D011689:Purkinje Cells / Q000166:cytology* / Q000378:metabolism; D012794:Sialic Acids / Q000378:metabolism
D011508:Chondroitin Sulfate Proteoglycans; D039842:Neural Cell Adhesion Molecule L1; D012794:Sialic Acids; C103469:polysialyl neural cell adhesion molecule